Literature DB >> 7263817

Determination of levamisole in plasma and animal tissues by gas chromatography with thermionic specific detection.

R Woestenborghs, L Michielsen, J Heykants.   

Abstract

A rapid and sensitive method has been developed for the determination of the anthelmintic levamisole in plasma and tissues from man and animals. The procedure involves the extraction of the drug and its internal standard from the biological material at alkaline pH, back-extraction into sulphuric acid and re-extraction into the organic phase (heptane-isoamyl alcohol). Several extraction steps can be omitted, however, whenever the gas chromatographic background permits and some operations can be simplified using Clin ElutTM extraction tubes. The analyses were carried out by gas chromatography using a nitrogen-selective thermionic specific detector. The detection limit was 5 ng, contained in 1 ml of plasma or in 1 g of the various tissues, and recoveries were sufficiently high (79-86%). The method was applied to human plasma samples in a comprehensive bioavailability study of levamisole in healthy volunteers, and to plasma and tissues in a residue trial in cattle. The effect of the blood collection technique on the plasma levels was also studied and pointed to decreased plasma concentrations when Vacutainer tubes were used.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7263817     DOI: 10.1016/s0378-4347(00)80134-6

Source DB:  PubMed          Journal:  J Chromatogr


  3 in total

Review 1.  Clinical pharmacokinetics of anthelmintic drugs.

Authors:  G Edwards; A M Breckenridge
Journal:  Clin Pharmacokinet       Date:  1988-08       Impact factor: 6.447

2.  Quantitation of levamisole in plasma using high performance liquid chromatography.

Authors:  T F Vandamme; M Demoustier; B Rollmann
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1995 Apr-Jun       Impact factor: 2.441

3.  The hairy-print for levamisole-induced vasculitis.

Authors:  Hélène Lazareth; Gilles Peytavin; Laura Polivka; Nicolas Dupin
Journal:  BMJ Case Rep       Date:  2012-08-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.